The enhanced inactivated poliovirus vaccine was first introduced in 2002, and several
inactivated poliovirus vaccines are licensed in Korea. Reliable data by a prospective study …

Purpose: We evaluated the immunogenicity and safety of eIPV (Imovax $ Polio^{(R)} $) in a
group of healthy Korean infants on a three-dose primary vaccination. Methods: Eighty one …

Enhanced potency inactivated poliovirus vaccine (EIPV), combined with diphtheria-tetanus-
pertussis (DTP) vaccine, was compared with oral poliovirus vaccine (OPV) regarding …

Objective To evaluate the immunogenicity and safety of a boost dose of inactivated polio
vaccine (IPV) among children aged 18 months who had been administered with primary …

Introduction Replacing live-attenuated oral poliovirus vaccines (OPV) with inactivated
poliovirus vaccines (IPV) is part of the global strategy to eradicate poliomyelitis. China was …

Objective As per the requirement of Korean Food and Drug Administration, this post-
marketing surveillance was conducted in Korea to evaluate the safety and reactogenicity of …

BACKGROUND Inactivated polio vaccine (IPV) was first introduced in the United States in
1955. Widespread distribution of over 400 million doses between 1955 and 1961 led to a …

This was a cross-sectional community-based serological survey of polio antibodies
assessing the immunogenicity of inactivated poliovirus vaccine (IPV) focusing on poliovirus …

Inactivated poliovirus vaccine (IPV) is the vaccine of choice for protection against paralytic
poliomyelitis provided that it is used within the context of a program to increase and sustain …

BACKGROUND: Oral poliovirus vaccine (OPV) remains the vaccine-of-choice for routine
immunization and supplemental immunization activities (SIAs) to eradicate poliomyelitis …